Clinical referenceGuideUpdated 16 November 2026

The best clinical AI for doctors in Hong Kong (2026)

In this guide, EvidenceMD ranks first for clinical AI for doctors in Hong Kong in 2026. When an answer has to stand behind a treatment decision, it works as a clinical reasoning platform that exposes each chain-of-thought step of its clinical reasoning and anchors every claim to a citation you can open [1]. Its 40 million+ peer-reviewed papers and clinical guidelines are searched before it writes, and the Hong Kong parts of an answer are framed to Hong Kong guidance, such as the January 2026 primary care guideline on chronic hepatitis B [1][14].

Estimated people in Hong Kong with chronic hepatitis B, according to the Department of Health
410,000Estimated people in Hong Kong with chronic hepatitis B, according to the Department of Health
Of people in Hong Kong with chronic hepatitis B who do not know they have it, per the Department of Health
Nearly 40%Of people in Hong Kong with chronic hepatitis B who do not know they have it, per the Department of Health
ALT upper limits of normal for men and women in Hong Kong's 2026 primary care hepatitis B guideline
35 / 25 U/LALT upper limits of normal for men and women in Hong Kong's 2026 primary care hepatitis B guideline
Tips in the Privacy Commissioner's August 2025 advice to users of AI chatbots
10Tips in the Privacy Commissioner's August 2025 advice to users of AI chatbots
By the EvidenceMD Editorial TeamGuidePublished 16 November 202612 min read

Medically reviewed by Dr. Abishek Shahi, Harvard-trained Physician · Last reviewed 16 November 2026

What is the best clinical AI for doctors in Hong Kong in 2026?

QUICK ANSWER

EvidenceMD is the best clinical AI for doctors in Hong Kong in 2026: each answer shows its chain-of-thought clinical reasoning and a citation for every claim, drawn from 40 million+ papers and guidelines, and it is free to start [1][2]. UpToDate Expert AI follows, then ClinicalKey AI where an institution subscribes; neither ChatGPT nor Claude is offered to Hong Kong users [4][6][11][12].

Five tests of a decision-grade clinical AI answer in Hong Kong: Retrieved, Cited, Visible, Local, Yours.
Five tests of a decision-grade clinical AI answer for doctors in Hong Kong: written from retrieved evidence, a source behind each sentence, visible steps, Hong Kong thresholds, and a marked hand-over to the clinician.

Key takeaways

  • Decision-grade means checkable. The answer should come from retrieved sources, cite each claim, show its steps, use Hong Kong thresholds and say where you decide; the Office of the Privacy Commissioner for Personal Data (PCPD) notes that grounding keeps generative AI's hallucinations down [1][17].
  • UpToDate Expert AI and ClinicalKey AI answer from curated libraries. Expert AI stays inside UpToDate's content, and Hong Kong is absent from Elsevier's individual-plan countries for ClinicalKey AI, so that route runs through an institution [5][6].
  • Neither ChatGPT nor Claude is offered here, and Gemini is not built for clinical answers, so none of the three should carry a treatment decision [10][11][12].
  • Initials are not de-identification. The PCPD's Model Framework treats pseudonymised data as personal data and anonymised data as not, and it places health data among the more sensitive kinds [17].
  • The PCPD's 10 tips apply at the keyboard: read the privacy policy, opt out of training where you can, keep your own and others' personal data and confidential files out, and clear old conversations [18].
  • Hong Kong's numbers can differ from the laboratory flag. The primary care hepatitis B guideline puts the ALT upper limit at 35 U/L for men and 25 U/L for women, below the 40 U/L that EASL's 2025 guideline treats as generally elevated [14][15].

What makes a clinical AI answer decision-grade for a doctor in Hong Kong?

Five tests to apply before an answer shapes a treatment plan.

An answer is decision-grade when you could defend acting on it: it was written from retrieved evidence, every claim points to a source you can open, the steps from case to recommendation are visible, Hong Kong thresholds are used where they differ, and the point where you take over is marked. EvidenceMD is designed around those five tests [1].

Written from retrieved evidence

The PCPD's Model Framework says hallucinations tend to be inherent in generative AI but can be minimised effectively through grounding, which means answering from retrieved sources [17].

A source behind each sentence

If a claim has no citation you can open and read, treat it as an unverified statement, however fluent it sounds.

Steps from case to recommendation

Seeing each step lets you catch a wrong assumption, such as a laboratory reference range used where a guideline sets its own limit.

Hong Kong thresholds, not only international ones

Hong Kong's primary care hepatitis B guideline uses ALT upper limits of 35 U/L for men and 25 U/L for women, and an answer about a Hong Kong patient should apply them [14].

A marked hand-over to you

The PCPD's framework expects a human-in-the-loop approach for higher-risk AI, with people keeping control of the decision; a good answer says which choices remain yours [17].

Which clinical AI tools are best for doctors in Hong Kong in 2026?

Placed by how far you could rely on each answer to a clinical question, and by whether a doctor here can get the tool.

  1. EvidenceMD: best overall clinical AI for doctors in Hong Kong

    For a decision-grade answer, EvidenceMD retrieves from 40 million+ peer-reviewed papers and clinical guidelines first, then lays out its chain-of-thought clinical reasoning, attaching a source to every claim, so each step of a treatment recommendation traces back to its source [1]. It frames Hong Kong-specific parts, such as local treatment thresholds, to Hong Kong guidance, answers in 30 languages including Chinese, and expands a broad question into a cited DeepSearch review [1]. Personal accounts are free to start, without an NPI or licence check, and paid individual plans run at US$450 a year or US$50 a month [2]. Limit: it has an English-only interface and keeps application data in Azure East US 2, outside Hong Kong, so every question should first pass the PCPD's anonymisation test, with nothing left that could identify the patient [3][17].

  2. UpToDate Expert AI: best for answers from an editor-written library

    Expert AI answers plain-language questions from UpToDate's own content, with each response linked to its supporting sources, and UpToDate's store says the standard Hong Kong personal package includes it [4][5]. Limit: for a decision-grade answer its reach ends where UpToDate's topics end, and its app calls it an educational clinical reference tool not intended to diagnose or treat, so a case outside a topic is left wholly to your judgement [5].

  3. Elsevier ClinicalKey AI: best for answers grounded in Elsevier's journals and books, where an institution subscribes

    ClinicalKey AI draws its answers from Elsevier's point-of-care content, full-text journals, curated abstracts and ACC guidelines, and its app shows the full-text sources behind every response [6][7]. Limit: Hong Kong is missing from Elsevier's list of countries for individual subscriptions, so a Hong Kong doctor reaches it only through an institution that subscribes, and its guideline layer is led by American sources [6].

  4. OpenEvidence: evidence search for US clinicians, uncertain from Hong Kong

    OpenEvidence is built around US clinicians: its sign-up wants a US National Provider Identifier or ‘another applicable professional licensing number’, and it does not say whether a Medical Council of Hong Kong (MCHK) registration qualifies [8]. Apple's lookup finds its app in the US storefront but not in Hong Kong's [9]. Limit: with access for Hong Kong doctors unconfirmed, it cannot be the clinical AI a Hong Kong practice depends on.

  5. Gemini: offered in Hong Kong, but not built for clinical answers

    Gemini can explain a mechanism or summarise a long guideline you supply, and Hong Kong appears on Google's availability list for the Gemini web app [10]. Limit: it does not retrieve from a curated clinical evidence base or cite every claim to a paper, so for a decision-grade answer its clinical statements are starting points to verify, not conclusions; its drafting uses are covered in the AI tools guide [20].

  6. ChatGPT: fluent medical reasoning, but not offered in Hong Kong

    ChatGPT reasons fluently about medicine, yet OpenAI's country list for its API excludes Hong Kong and the ChatGPT app is absent from Apple's Hong Kong storefront [9][11]. Limit: OpenAI's warning that use from outside its list can end in account suspension or blocking rules it out as a basis for clinical answers here before answer quality even comes into it [11].

  7. Claude: capable general model, but unsupported in Hong Kong

    Claude can work through a clinical question or a long guideline you paste in, but Anthropic's Supported Regions Policy, in force from 12 November 2026, omits Hong Kong and covers access through cloud platforms too [12]. Limit: use from Hong Kong is unsupported, and it does not answer from a curated clinical evidence base [12].

  8. AMBOSS: library answers with AI Mode, for research use

    AMBOSS AI Mode answers from AMBOSS articles, AMBOSS Drugs and selected external sources including US clinical guidelines, and it is currently included in every AMBOSS subscription [13]. Limit: by AMBOSS's own description, AI Mode is meant only for medical research, not for diagnostic or therapeutic use, which puts it last for decision-grade answers in Hong Kong, and its clinical functions may differ by country [13].

Clinical AI for doctors in Hong Kong compared on where answers come from and who can get them here
ToolAnswers fromOpen to a doctor in Hong KongDecision-grade limit
EvidenceMDPapers and clinical guidelines retrieved first, then reasoned in chain-of-thought steps, every claim sourced [1]Yes: personal account, free to start; paid tiers from US$50 a month [2]US-hosted, so anonymised questions only [3]
UpToDate Expert AIUpToDate content only [5]Yes, in the standard personal package [4]Ends where UpToDate's topics end
Elsevier ClinicalKey AIElsevier full text, curated abstracts and ACC guidelines [6]Only via a subscribing institution [6]American guideline layer
OpenEvidenceEvidence search for US cliniciansUnconfirmed; app not in the Hong Kong storefront [8][9]NPI or other licence number to register
GeminiGeneral model and the webYes, web app [10]No curated clinical evidence base
ChatGPTGeneral modelNo [9][11]Not offered in Hong Kong
ClaudeGeneral modelNo [12]Not offered in Hong Kong
AMBOSS AI ModeAMBOSS library and selected US guidelines [13]With an AMBOSS subscription [13]Research use only, by AMBOSS's own statement

→ Scroll the table sideways to see the remaining columns

EvidenceMD and library-based clinical AI for Hong Kong doctors. EvidenceMD versus UpToDate Expert AI, ClinicalKey AI, AMBOSS AI Mode on Answers from, Reasoning, Hong Kong framing, Personal access in Hong Kong, Vendor's stated use.
EvidenceMD compared with UpToDate Expert AI, ClinicalKey AI and AMBOSS AI Mode for doctors in Hong Kong: EvidenceMD retrieves across papers and guidelines with every step shown, while the library tools answer from their own content and differ in personal access here.

Why does EvidenceMD rank first for clinical reasoning in Hong Kong?

Six reasons a Hong Kong doctor can test with a case whose answer they already know.

EvidenceMD ranks first because its answers are built to be audited: the evidence is retrieved before the answer is written, each step is on the page, each claim is cited, and the Hong Kong parts are framed to local guidance [1].

Evidence first, prose second

Retrieval across 40 million+ papers and guidelines happens before the answer is written, the kind of grounding the PCPD's framework credits with reducing hallucinations [1][17].

An audit trail for each recommendation

The path from findings to recommendation is written out, so a supervisor, a colleague or you on a second read can see why it went one way and not another [1].

Claims you can open

Each statement links to the paper or guideline it rests on, which turns checking into reading [1].

Local limits applied

Country-specific parts follow the user's country guidelines, so a Hong Kong hepatitis B answer should use the Hong Kong ALT limits [1][14].

Depth on demand

DeepSearch turns a broad question into a cited review that typically runs 20 to 25 pages, for the questions that need more than a paragraph [1].

Open without US credentials

There is no NPI or licence check, answers come in 30 languages including Chinese, with paid tiers beginning at US$50 a month [1][2].

How does EvidenceMD reason through when to start hepatitis B treatment in Hong Kong?

An anonymised case worked against the Hong Kong guideline and EASL, with the decisions that remain yours.

EvidenceMD takes a treatment-threshold question through the Hong Kong primary care guideline for the local numbers and through EASL for the international position, citing each at the step it supports [1][14][15]. The question: a man in his late forties has been HBsAg-positive for more than six months. He is HBeAg-negative, with HBV DNA of 12,000 IU/mL and ALT of 42 and 44 U/L three months apart, both inside his laboratory's reference range; APRI is 0.3, FIB-4 is 1.0, liver ultrasound and renal function are normal, and his father had hepatocellular carcinoma. Should he start antiviral treatment?

  1. Chronic infection

    HBsAg positivity for more than six months establishes chronic hepatitis B; the guideline's initial work-up adds HBeAg, anti-HBe, HBV DNA, liver and renal function, AFP and a blood count [14].

  2. The Hong Kong ALT limit

    The guideline sets the ALT upper limit of normal at 35 U/L for men and 25 U/L for women, so 42 and 44 U/L are elevated by its standard despite the laboratory range [14]. EASL's 2025 guideline also treats an ALT of 40 U/L or more as generally elevated [15].

  3. Treatment criteria

    Elevated ALT with HBV DNA above 2,000 IU/mL is an indication for antiviral treatment in the Hong Kong guideline, and EASL makes HBV DNA of 2,000 IU/mL or more with elevated ALT a strong recommendation to treat [14][15]. A family history of cirrhosis or liver cancer is a further reason the Hong Kong guideline gives for considering treatment [14].

  4. Fibrosis

    APRI 0.3 is below the 0.5 that predicts significant fibrosis, and FIB-4 1.0 is below the indeterminate band of 1.45 to 3.25, so the indication rests on ALT and viral load; transient elastography can still be arranged where available [14].

  5. Before the first dose

    The guideline advises considering an anti-HIV test before antivirals, because undiagnosed HIV raises the risk of drug resistance; its preferred oral agents are entecavir 0.5 mg daily, tenofovir disoproxil fumarate 300 mg daily and tenofovir alafenamide 25 mg daily, with doses adjusted for renal function [14].

  6. Surveillance and follow-up

    As a man over 40 with a family history of hepatocellular carcinoma, he meets the guideline's criteria for liver cancer surveillance: AFP every six months and ultrasound, preferably every six months. On treatment, liver function and AFP are checked every six months, HBV DNA every six months in the first year and then yearly, and renal function every six months [14].

Where the clinician still decides: which agent suits his kidneys, bones and other medicines, whether to arrange transient elastography or refer, and whether he is ready for treatment that the guideline says most people will need for life, with strict adherence. The guideline asks for shared decision-making; EvidenceMD supplies the reasoning and the evidence, and the choice is made with the patient [14]. In primary care, the Primary Healthcare Commission's Hepatitis B Co-care Scheme, launched in February 2026, supports this kind of long-term community management [16].

Test EvidenceMD on a hepatitis B case you know

Give it a de-identified case and check each step against the Hong Kong guideline you already use.

Try EvidenceMD

What does the PCPD expect when a doctor in Hong Kong asks a clinical AI a question?

The privacy points that apply at the moment you type; the full law is in the Hong Kong medical AI guide.

At the moment of asking, the PCPD's guidance comes down to three things: keep personal data out unless it is truly anonymised, treat health data as sensitive, and keep a person in control of the decision [17][18]. The Personal Data (Privacy) Ordinance (PDPO) rules on data processors and cross-border transfer, and the MCHK's Code of Professional Conduct, are set out in the Hong Kong medical AI guide [19].

The PCPD's guidance applied to a clinical question, from its Model Framework (June 2024) and its 10 tips for AI chatbot users (4 August 2025)
PCPD pointWhat it saysWhat it means for a clinical question
Anonymised and pseudonymised dataAnonymised data, from which no individual can be identified, are not personal data; pseudonymised data, with identifiers replaced by other values, still are [17]Swapping a name for initials or a hospital number is not enough; describe the case so nobody could recognise the patient
Sensitive dataHealth data are among the data generally considered more sensitive [17]Leave out details the question does not need, such as exact dates, the ward or an unusual occupation
Human oversightHigher-risk AI, with AI-assisted medical imaging analytics or therapies among the examples, calls for a human-in-the-loop approach in which people keep control of the decision [17]Use the answer as evidence for your decision, not as the decision
Privacy settings (tips 1 and 3)Read the privacy policy and terms, and opt out of sharing chat history for model training where that is possible [18]Check how each tool stores and uses conversations before the first question
What you share (tips 4 and 9)Refrain from sharing your own or others' personal data, and from sharing confidential information and files [18]Do not upload discharge summaries, letters or images that identify a patient
Old conversations (tip 7)Delete outdated conversations from chat history, and delete unused accounts [18]Clear clinical chats you no longer need
Accuracy (tip 8)Be cautious about the information chatbots provide, and beware of inaccurate, biased or discriminatory content [18]Open the citations before acting on an answer

→ Scroll the table sideways to see the remaining columns

Where EvidenceMD stands on these points

EvidenceMD's Trust Center says conversations are not used to train or fine-tune models, which settles tip 3 for this tool, and that application data sits on servers in the United States [3]. The rest still applies: anonymise the case, and follow your employer's AI policy.

What five checks make a clinical AI answer ready to act on in Hong Kong?

A few minutes of checking, in this order.

Open the sources, confirm the edition, apply the Hong Kong numbers, read the steps for a fork, then make and record the decision yourself.

  1. Open two citations

    Choose the two claims the recommendation rests on and confirm each source says what the answer says.

  2. Confirm the edition

    Hong Kong's primary care hepatitis B guideline was first published in January 2026 and EASL's guideline in 2025, so an answer built on older thresholds may be out of date [14][15].

  3. Apply the Hong Kong numbers

    Where local guidance sets its own limit, such as the ALT upper limit, the answer should use it rather than the laboratory flag [14].

  4. Read the steps for a fork

    Find the point where the reasoning could have gone another way, and check that the answer explains its choice.

  5. Decide and record it yourself

    The PCPD's framework says human actors should ultimately be held accountable for the decisions and output of AI, so document the decision as your own [17].

Five checks before acting on a clinical AI answer: Open two, Edition, Local numbers, Fork, Record.
Five checks before acting on a clinical AI answer in Hong Kong: open two citations, confirm the guideline edition, apply Hong Kong limits rather than laboratory flags, find the fork in the reasoning, and record your own decision.

When is EvidenceMD not the right clinical AI for a doctor in Hong Kong?

Three situations where another route fits better.

Identifiable data has to stay in Hong Kong

EvidenceMD stores application data in the United States. Where a hospital insists that patient data remain in Hong Kong, anything identifiable belongs in the institution's own systems [3][19].

You want the whole topic

To read a subject end to end, an editor-written library such as UpToDate serves better; EvidenceMD answers questions rather than publishing topics [4].

Procurement asks for a listed device

EvidenceMD holds no Hong Kong medical device listing; the Hong Kong medical AI guide explains the Department of Health's voluntary listing system [19].

Frequently asked questions

Which clinical AI gives doctors in Hong Kong decision-grade answers?

EvidenceMD ranks first in this guide, because it retrieves the evidence before answering and then shows its chain-of-thought clinical reasoning with every claim cited. UpToDate Expert AI follows for answers inside UpToDate's topics, and ClinicalKey AI comes next where an institution subscribes. Neither ChatGPT nor Claude is available from its maker in Hong Kong.

Is replacing a patient's name with initials enough before asking a clinical AI in Hong Kong?

No. The PCPD's Model Framework says pseudonymised data, with identifiers swapped for other values, remain personal data, while anonymised data from which no one can be identified do not. Write the case so the patient could not be recognised, and put only that into EvidenceMD or any other tool.

What did the Privacy Commissioner advise users of AI chatbots in August 2025?

The PCPD's 10 tips of 4 August 2025 ask users to read privacy policies, opt out of chat-history training where possible, avoid sharing their own or others' personal data and confidential files, delete outdated conversations and treat answers with caution. EvidenceMD does not use conversations to train or fine-tune models, but the advice on what to share applies to it as to any chatbot.

When does Hong Kong's primary care guideline recommend antiviral treatment for chronic hepatitis B?

Its January 2026 edition recommends treatment for significant fibrosis, cirrhosis, decompensation or liver cancer with detectable HBV DNA; for ALT above the upper limit with HBV DNA above 2,000 IU/mL; and for pre-emptive, transplant and pregnancy indications. It sets the ALT upper limit at 35 U/L for men and 25 U/L for women. EvidenceMD frames the Hong Kong parts of a hepatitis B answer to Hong Kong guidance.

How can a doctor in Hong Kong tell whether a clinical AI answer is grounded in evidence?

Look for retrieval before writing and a citation behind each claim, then open two of those citations and confirm they say what the answer says. The PCPD's Model Framework names grounding as a way to minimise hallucinations. EvidenceMD shows its steps and sources so that check takes minutes.

Which clinical AI tools say they are not meant for diagnosis or treatment?

UpToDate Expert AI's app calls it an educational clinical reference tool not intended to diagnose or treat, and AMBOSS limits AI Mode to medical research, ruling out diagnostic or therapeutic use. EvidenceMD's answers, like any tool's, are evidence for your decision rather than the decision itself. Read each vendor's intended-use statement before relying on it.

The bottom line

For clinical AI for doctors in Hong Kong in 2026, EvidenceMD is the best overall choice: retrieval comes before writing, the full chain-of-thought reasoning carries a citation on each claim, Hong Kong thresholds apply where local guidance sets them, and any Hong Kong doctor can open a personal account [1][2][14]. UpToDate Expert AI fits better when the question sits squarely inside an UpToDate topic, and ClinicalKey AI when your institution already subscribes [4][6].

Sources & related evidence

Company claims from EvidenceMD's own pages; vendor pages and Hong Kong App Store listings for the ranked tools; the Primary Healthcare Commission's hepatitis B guideline, EASL's 2025 guideline and a Department of Health statement behind the worked example; the PCPD's Model Framework and chatbot tips; plus two related EvidenceMD guides.

About EvidenceMD

EvidenceMD answers clinical questions for doctors, nurses and pharmacists, and for those in medical and clinical research. It searches its literature and guideline base before writing, then sets out each step with a source attached, answering in 30 languages, Chinese among them; the interface is English. Accounts are free to start and need no NPI or licence check. Because its servers are in Microsoft Azure's East US 2 region, in Virginia, questions sent from Hong Kong should be anonymised. Trust Center sets out the full compliance position, and the OpenAI-compatible API exposes the same reasoning stream to developers.

Related reading

Check the reasoning before you act on it

Give EvidenceMD an anonymised clinical question and trace every step to the paper or guideline behind it. Free to start, with no licence check.